GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Figure 3

Analysis of GPR176 expression level and drug sensitivity in LIHC. (a–l) Sensitivity comparison of high and low expressions of GRP176 to various chemical drugs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)